All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First commercial cases of laser-based, non-incisional trabeculotomy procedure ➤ FDA grants appeal, allowing for BLA resubmission of AMD treatment ➤ Study: small-aperture IOL safe, effective for irregular corneas ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
A symposium at the 2026 ASCRS Annual Meeting—“Robotic Surgery: How Soon and How Good Will It Be?”—gave an overview of robotic cataract surgery and its future with perspectives from physicians who were directly involved with these rapidly advancing technologies.
➤ CPT code granted to investigational drug-eluting IOL system ➤ Study: new eye disease associated with virus ➤ Enrollment complete in real-world myopia control studies ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA 510(k) clearance granted to non-invasive glaucoma treatment ➤ Study: GA treatment increases probability of driving capabilities among patients ➤ Third implantation of wireless visual prosthesis in the brain ➤ First-in-human results for geographic atrophy therapy ➤ SPA agreement with the FDA for optic neuritis trial ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Topline results from Phase 2/3 study for uveal melanoma treatment ➤ Study evaluates spatial computing in cataract surgery with Apple Vision Pro ➤ Updates in DME treatment trials ➤ Company news ➤ ASCRS news and events
➤ 36-month results from first-in-human study with shape-changing IOL ➤ New data for recently approved EDOF IOL ➤ Company completes first-in-human robotic cataract surgery ➤ Phase 2 study approved for secondary IOL intended for low-vision patients ➤ Investigational device measures real-time intraoperative aqueous outflow ➤ FDA expands dosing on label for faricimab ➤ Company news ➤ ASCRS news and events
➤ Keep up with ASCRS Annual Meeting coverage with EyeWorld Onsite ➤ Positive topline results from Phase 3 trial for TED drug with new delivery method ➤ FDA expands dosing interval for wet AMD, DME treatment ➤ IDE granted to noninvasive bioelectric stimulation therapy for dry AMD ➤ First patients dosed in Phase 3 corneal cell therapy ➤ TED investigational treatment fails to meet primary endpoint ➤ OTC eye drop recall after FDA enforcement report cites sterility concerns ➤ ASCRS news and events
Oral sedation for cataract surgery has been used in some capacity for at least the last 20 years in the U.S., and discussion has begun on whether oral sedation options could become the primary care model within ASCs and hospital settings. Three cataract surgeons weighed in on the topic.
Two physicians shared their thoughts on the various ways to manage astigmatism, what levels to treat, and how they decide the best option for each patient.
Get the latest ophthalmology news delivered to your inbox every Friday.